Qingdao Haier Biomedical Co., Ltd.: Future Focus on Four Key Industries

Deep News10-16

On October 16, Qingdao Haier Biomedical Co., Ltd. responded to investor inquiries on its interactive platform, stating that according to business registration information, the controlling shareholder of the current stock acquirer is Qingdao Guoxin Financial Holdings Co., Ltd., with the actual controller being the State-owned Assets Supervision and Administration Commission of the Qingdao Municipal Government. The increase in shareholding by this state-owned entity is based on a long-term optimistic outlook on the future development of the life sciences industry, as well as recognition of Qingdao Haier Biomedical's performance in corporate governance, industry position, business capabilities, operating results, and risk management. This investment is driven by its own investment planning and analysis of the listed company's investment value, aiming to achieve synergistic win-win outcomes in future development. Going forward, Qingdao Haier Biomedical will continue to deepen its engagement in four key industries, strengthen the integration of AI technology systems with life sciences and medical innovation scenarios, and accelerate its globalization process, providing returns for a broad base of investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137269989?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-16 21:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137269989","market":"us","top_or_hot":-1,"title":"Qingdao Haier Biomedical Co., Ltd.: Future Focus on Four Key Industries","media":"Deep News","content":"<p>On October 16, Qingdao Haier Biomedical Co., Ltd. responded to investor inquiries on its interactive platform, stating that according to business registration information, the controlling shareholder of the current stock acquirer is Qingdao Guoxin Financial Holdings Co., Ltd., with the actual controller being the State-owned Assets Supervision and Administration Commission of the Qingdao Municipal Government. The increase in shareholding by this state-owned entity is based on a long-term optimistic outlook on the future development of the life sciences industry, as well as recognition of Qingdao Haier Biomedical's performance in corporate governance, industry position, business capabilities, operating results, and risk management. This investment is driven by its own investment planning and analysis of the listed company's investment value, aiming to achieve synergistic win-win outcomes in future development. Going forward, Qingdao Haier Biomedical will continue to deepen its engagement in four key industries, strengthen the integration of AI technology systems with life sciences and medical innovation scenarios, and accelerate its globalization process, providing returns for a broad base of investors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qingdao Haier Biomedical Co., Ltd.: Future Focus on Four Key Industries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQingdao Haier Biomedical Co., Ltd.: Future Focus on Four Key Industries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-10-16 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On October 16, Qingdao Haier Biomedical Co., Ltd. responded to investor inquiries on its interactive platform, stating that according to business registration information, the controlling shareholder of the current stock acquirer is Qingdao Guoxin Financial Holdings Co., Ltd., with the actual controller being the State-owned Assets Supervision and Administration Commission of the Qingdao Municipal Government. The increase in shareholding by this state-owned entity is based on a long-term optimistic outlook on the future development of the life sciences industry, as well as recognition of Qingdao Haier Biomedical's performance in corporate governance, industry position, business capabilities, operating results, and risk management. This investment is driven by its own investment planning and analysis of the listed company's investment value, aiming to achieve synergistic win-win outcomes in future development. Going forward, Qingdao Haier Biomedical will continue to deepen its engagement in four key industries, strengthen the integration of AI technology systems with life sciences and medical innovation scenarios, and accelerate its globalization process, providing returns for a broad base of investors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688139","symbol_name":"海尔生物","start_time":0,"source_url":"","article_id":"1137269989","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137269989","pubTimestamp":1760621479,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On October 16, Qingdao Haier Biomedical Co., Ltd. responded to investor inquiries on its interactive platform, stating that according to business registration information, the controlling shareholder...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688139":"海尔生物","BK0251":"专用设备","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC"},"translate_title":"青岛海尔生物医疗股份有限公司：未来聚焦四大重点产业","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688139":1},"content_text":"On October 16, Qingdao Haier Biomedical Co., Ltd. responded to investor inquiries on its interactive platform, stating that according to business registration information, the controlling shareholder of the current stock acquirer is Qingdao Guoxin Financial Holdings Co., Ltd., with the actual controller being the State-owned Assets Supervision and Administration Commission of the Qingdao Municipal Government. The increase in shareholding by this state-owned entity is based on a long-term optimistic outlook on the future development of the life sciences industry, as well as recognition of Qingdao Haier Biomedical's performance in corporate governance, industry position, business capabilities, operating results, and risk management. This investment is driven by its own investment planning and analysis of the listed company's investment value, aiming to achieve synergistic win-win outcomes in future development. Going forward, Qingdao Haier Biomedical will continue to deepen its engagement in four key industries, strengthen the integration of AI technology systems with life sciences and medical innovation scenarios, and accelerate its globalization process, providing returns for a broad base of investors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137269989","isCrawlerRequest":true}